Science ❯ Biotechnology

Pharmaceuticals

Clinical Trials Drug Development Vaccine Development Antibody Development Drug Discovery Genetic Research Antibiotic Development Cancer Vaccines Research Security Drug Companies Protein Delivery Systems Drug Delivery Systems Investment Strategies Monoclonal Antibodies Research and Development Antibiotic Resistance Weight Loss Drugs Vaccine Technology Moderna Vaccine Innovation Fertility Drugs Clinical Research Drug Formulation AVEO Pharmaceuticals Acquisition

Biogen Licenses Vanqua’s Preclinical C5aR1 Drug in Deal Worth Up to $1.06 Billion

The company is targeting an FDA IND in 2027 contingent on supportive preclinical data.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2025 Mina Labs Inc.